Immutep Ltd
IMMP1.710USD
-0.010-0.58%
交易中 （美东）报价延迟15分钟
2.49B总市值
--市盈率 TTM
关于 Immutep Ltd 公司
Immutep Limited 是一家位于澳大利亚的临床阶段生物技术公司。该公司专注于开发用于治疗癌症和自身免疫性疾病的淋巴细胞活化基因 (LAG)-3 免疫疗法。其主要候选产品 Eftilagimod alpha (efti 或 IMP321) 是一种可溶性 LAG-3Ig 融合蛋白，是一种抗原呈递细胞 (APC) 激动剂，旨在利用 LAG-3 驱动适应性和先天免疫系统对抗癌症的能力。IMP761 是一种针对 LAG-3 的免疫抑制激动剂抗体，它有可能通过特异性沉默自身免疫记忆 T 细胞来解决自身免疫性疾病的根本原因。其第三个候选产品是 LAG525，这是一种针对 T 细胞上的 LAG-3 分子的拮抗剂（阻断）抗体，可用于治疗癌症。其第四个候选产品是IMP731（GSK 781），一种消耗性（细胞毒性）抗体，旨在破坏参与自身免疫的表达LAG-3的活化T细胞。
公司简介
公司代码IMMP
公司名称Immutep Ltd
上市日期Jun 23, 1988
CEOMr. Marc Voigt
员工数量- -
证券类型Depository Receipt
年结日Jun 23
公司地址Level 32, Suite 32.07 Australia Square
城市SYDNEY
上市交易所NASDAQ Global Market Consolidated
国家Australia
邮编2000
电话61283157003
网址https://www.immutep.com/
公司代码IMMP
上市日期Jun 23, 1988
CEOMr. Marc Voigt
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Frederic Triebel, M.D., Ph.D.
Dr. Frederic Triebel, M.D., Ph.D.
Chief Scientific Officer, Executive Director
Chief Scientific Officer, Executive Director
17.06K
--
Mr. Marc Voigt
Mr. Marc Voigt
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
45.00
--
Ms. Lis (Elisabeth) Boyce
Ms. Lis (Elisabeth) Boyce
Non-Executive Director
Non-Executive Director
--
--
Ms. Indira Naidu
Ms. Indira Naidu
Joint Company Secretary
Joint Company Secretary
--
--
Mr. Peter A. (Pete) Meyers
Mr. Peter A. (Pete) Meyers
Independent Non-Executive Deputy Chairman of the Board
Independent Non-Executive Deputy Chairman of the Board
--
--
Ms. Deanne Miller
Ms. Deanne Miller
Chief Operating Officer, General Counsel, Joint Company Secretary
Chief Operating Officer, General Counsel, Joint Company Secretary
--
--
Dr. Russell John Howard, Ph.D.
Dr. Russell John Howard, Ph.D.
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Catherine Strong
Ms. Catherine Strong
Investor Relations
Investor Relations
--
--
Dr. Stephan Winckels
Dr. Stephan Winckels
Chief Medical Officer
Chief Medical Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Frederic Triebel, M.D., Ph.D.
Dr. Frederic Triebel, M.D., Ph.D.
Chief Scientific Officer, Executive Director
Chief Scientific Officer, Executive Director
17.06K
--
Mr. Marc Voigt
Mr. Marc Voigt
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
45.00
--
Ms. Lis (Elisabeth) Boyce
Ms. Lis (Elisabeth) Boyce
Non-Executive Director
Non-Executive Director
--
--
Ms. Indira Naidu
Ms. Indira Naidu
Joint Company Secretary
Joint Company Secretary
--
--
Mr. Peter A. (Pete) Meyers
Mr. Peter A. (Pete) Meyers
Independent Non-Executive Deputy Chairman of the Board
Independent Non-Executive Deputy Chairman of the Board
--
--
Ms. Deanne Miller
Ms. Deanne Miller
Chief Operating Officer, General Counsel, Joint Company Secretary
Chief Operating Officer, General Counsel, Joint Company Secretary
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月2日 周三
更新时间: 7月2日 周三
持股股东
股东类型
持股股东
持股股东
占比
Pengana Capital Group Limited
0.66%
BlackRock Institutional Trust Company, N.A.
0.44%
Meridian Wealth Management, LLC
0.26%
AllianceBernstein L.P.
0.10%
XY Capital Ltd.
0.09%
Other
98.45%
持股股东
持股股东
占比
Pengana Capital Group Limited
0.66%
BlackRock Institutional Trust Company, N.A.
0.44%
Meridian Wealth Management, LLC
0.26%
AllianceBernstein L.P.
0.10%
XY Capital Ltd.
0.09%
Other
98.45%
股东类型
持股股东
占比
Investment Advisor
0.95%
Investment Advisor/Hedge Fund
0.80%
Hedge Fund
0.08%
Research Firm
0.04%
Individual Investor
0.01%
Other
98.12%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
56
2.80M
1.91%
-1.09M
2025Q1
57
2.80M
1.92%
-1.15M
2024Q4
60
6.95M
4.78%
-4.23M
2024Q3
60
9.14M
6.30%
-2.51M
2024Q2
63
9.65M
6.65%
+2.67M
2024Q1
67
3.50M
2.94%
-1.44M
2023Q4
66
3.16M
2.65%
-1.77M
2023Q3
71
3.00M
2.53%
-4.97M
2023Q2
73
3.42M
3.09%
-6.79M
2023Q1
63
4.23M
4.80%
-5.69M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Pengana Capital Group Limited
970.61K
0.66%
--
--
Feb 28, 2025
BlackRock Institutional Trust Company, N.A.
648.31K
0.44%
-92.10K
-12.44%
Mar 31, 2025
Meridian Wealth Management, LLC
386.65K
0.26%
-7.50K
-1.90%
Mar 31, 2025
AllianceBernstein L.P.
140.05K
0.1%
+61.92K
+79.25%
Jun 30, 2024
XY Capital Ltd.
136.74K
0.09%
-27.91K
-16.95%
Mar 31, 2025
Steward Partners Investment Advisory, LLC
61.00K
0.04%
+61.00K
--
Mar 31, 2025
Jane Street Capital, L.L.C.
51.57K
0.04%
+6.62K
+14.72%
Mar 31, 2025
Susquehanna International Group, LLP
47.46K
0.03%
-68.66K
-59.13%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
45.49K
0.03%
--
--
Mar 31, 2025
Citadel Advisors LLC
37.04K
0.03%
+35.58K
+2447.32%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Biotechnology ETF
0.02%
DFA Dimensional International Small Cap ETF
0%
ActivePassive International Equity ETF
0%
iShares Biotechnology ETF
占比0.02%
DFA Dimensional International Small Cap ETF
占比0%
ActivePassive International Equity ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
